Canada’s Drug Agency is announcing recent and upcoming changes to the leadership of our Canadian Drug Expert Committee (CDEC), pan-Canadian Oncology ...
Canada’s Drug Agency is launching a new 1-year learning period in our Scientific Advice program that will expand the type of guidance we offer to drug ...
New guidance from an expert panel offers recommendations on minimum retesting intervals for 5 laboratory tests that are commonly repeated in hospitals ...
In mid-March, we identified a cybersecurity incident in which an external party gained access to an application in our IT systems. We discovered the ...